High Concentration Of Stabilized Hyaluronic Acid
HYLO refers to High Molecular Weight Hyaluronic Acid (H-HA) and Low Molecular Weight Hyaluronic Acid (L-HA). It is a proprietary technology developed by FHL for the production of Fulloria, utilizing a specialized method that involves precise temperatures and stirring/mixing speeds. The HYLO technology aims to enhance the covalent bonds of the existing hyaluronic acid while also promoting ongoing skin regeneration through the strategic arrangement of the hyaluronic acid molecules.
Structural stability is enhanced without the need of a crosslinking agent through FHL’s proprietary formulation and manufacturing process.
Once administered, FULLORIA permeates the tissue and interacts uniquely with each layer of the skin.
High and Low HA FULLORIA creates the ideal physiological conditions for the proliferation, migration and organization of keratinocytes, fibroblasts and adipocytes.
Forest Hills Lab is an innovative regenerative therapy company composed of two distinct divisions specializing in Neuroscience and Aesthetics.
FHL Aesthetics’ product offering is rooted in our medical-grade injectable solutions. Our innovative medical- and cosmetic-grade aesthetics portfolio builds on that scientific and clinical base while directly addressing patient and clinician demand for higher efficacy, less treatment-related downtime, and more flexible treatments.
Designed, developed, and produced by FHL’.s leading in-house Korean R&D and CE - and GMP - certified manufacturing facilities as well as through high-value partnerships, our comprehensive and complementary portfolio delivers new treatment paradigms to global markets.
Our products are distributed globally with regulatory approvals and certifications in numerous jurisdictions driving rapid sales growth.
FHL’s offices in Hong Kong, Singapore, Korea, and the United States advance our clinical development, manufacturing, sales and marketing efforts the world over.